Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Imatinib-Induced Psoriasis
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Imatinib-Induced Psoriasis

Bibliographic Details
Published in:Turkish Journal of Hematology
Main Authors: Figen Atalay, Ebru Kızılkılıç, R. Simin Ada
Format: Article
Language:English
Published: Turkish Society of Hematology 2013-06-01
Subjects:
chronic myelogenous leukemia
imatinib
psoriasis
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-23230
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-23230

Similar Items

  • Does thyroid dysfunction happen in CML patients receiving Imatinib for treatment?
    by: Hossein Rahimi, et al.
    Published: (2015-01-01)
  • Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia
    by: Hyacinthe Johnson-Ansah, et al.
    Published: (2022-08-01)
  • Imatinib Therapy in Chronic Myelogenous Leukemia and Thyroid Function Tests
    by: Mohammad Ali Mashhadi, et al.
    Published: (2014-09-01)
  • Imatinib Mesylate (STI 571) – A New Oral Target Therapy For Chronic Myelogenous Leukemia (CML)
    by: Ladislav Chrobák, et al.
    Published: (2003-01-01)
  • Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib
    by: Phatchanat Klaihmon, et al.
    Published: (2024-02-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs